A Phase I Clinical Study of the Safety and Performance of the Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
Sponsor study identifier
interventional
30
1 country
6
Study Start
June 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2013
Actual (reported)Study Completion
June 2017
Actual (reported)The primary goal of the study is to assess the safety and performance of the Treovance device in subjects with infrarenal aortic aneurysms, specifically to evaluate if the diseased pathology can be treated with an acceptable adverse event rate and that the device performs as expected. The results of this study will permit the establishment of endpoints and clinical design for a subsequent U.S. trial.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 31, 2011
Actual (reported)April 4, 2011
Actual (reported)June 2011
Date type not reportedThis date has not been verified as actual or estimated.
April 2013
Actual (reported)June 2017
Actual (reported)major morbidity and mortality
1, 6, 12 months
Device performance
implant, 1, 6, and 12 months
Stent-graft implant
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University of Massachusetts
Worcester, Massachusetts, 01655, United States
Spectrum Health System
Grand Rapids, Michigan, 49503, United States
Carolinas Sanger Heart and Vascular
Charlotte, North Carolina, 28203, United States
East Carolina University
Greenville, North Carolina, 27834, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Sentara Heart Hospital
Norfolk, Virginia, 22042, United States
30 participants (actual enrollment reported by the registry).
First Submitted
March 31, 2011
First Posted
April 4, 2011
Study Start
June 2011
Date type not reportedThis date has not been verified as actual or estimated.
Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms
Contact the study team to confirm eligibility.
Primary Completion
April 2013
Actual (reported)Study Completion
June 2017
Actual (reported)Last Updated
December 20, 2017
Record last verified: 2017-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: